"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...
There’s new progress in the battle against Alzheimer’s disease. About 1 in 9 US seniors has Alzheimer’s, the most common form of dementia, which slowly impairs memory, thinking skills and the ability ...
A simple pinprick blood test is emerging as a potential game-changer, capable of detecting disease signs up to a decade before symptoms appear. By analyzing hundreds of molecules, researchers are ...
Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease. Will these tests change how cognitive decline is measured? A new blood ...
The first hints that Gregory Nelson might be having cognitive troubles were subtle. So subtle, in fact, that his doctor assured him nothing was wrong. “Everyone who hits a certain age just misses ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A major Alzheimer’s ...
Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...
A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. Using a multicancer early detection test, they identified tumor-derived genetic ...
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results